Location: Austin, TX
CIK: 0001019231 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 6, 2021
Total Value: $130M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TSHA | TAYSHA GENE THERAPIES INC | 1,391,190 | $29.49M | 22.6% | $23.82 | -3.2% | COM | 877619106 |
| BEAM | BEAM THERAPEUTICS INC | 224,391 | $28.88M | 22.2% | $95.13 | -16.2% | COM | 07373V105 |
| — | ELLIOTT OPPORTUNITY II CORP | 2,000,000 | $20.02M | 15.4% | $10.01 | — | COM | G30092129 |
| VT | VANGUARD TOTAL WORLD STOCK ETF | 158,484 | $16.42M | 12.6% | $80.77 | — | ETFS | 922042742 |
| — | CODIAK BIOSCIENCES INC | 847,108 | $15.7M | 12.0% | $15.08 | — | COM | 192010106 |
| IMTX | IMMATICS NV | 697,431 | $8.097M | 6.2% | $10.53 | +11.5% | COM | N44445109 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $6.154M | 4.7% | $57.24 | +186.9% | COM | 882508104 |
| — | AEGLEA BIOTHERAPEUTICS INC | 269,578 | $1.876M | 1.4% | $6.41 | — | COM | 00773J103 |
| — | SOLITON INC | 75,000 | $1.687M | 1.3% | $10.98 | — | COM | 834251100 |
| — | PLX PHARMA INC | 62,673 | $865K | 0.7% | $6.14 | — | COM | 72942A107 |
| — | PIONEER NATURAL RESOURCES CO | 3,656 | $594K | 0.5% | $162.47 | — | COM | 723787107 |
| — | TFF PHARMACEUTICALS INC | 22,066 | $212K | 0.2% | $18.47 | — | COM | 87241J104 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $164K | 0.1% | $7.34 | -34.4% | COM | 528872302 |
| — | APOLLO ENDOSURGERY INC | 15,601 | $126K | 0.1% | $2.24 | — | COM | 03767D108 |
| WY | WEYERHAEUSER CO | 1,000 | $34,000 | 0.0% | $30.53 | 0.0% | COM | 962166104 |
| AAPL | APPLE INC | 200 | $27,000 | 0.0% | $126.45 | 0.0% | COM | 037833100 |
| UNH | UNITEDHEALTH GROUP INC | 25 | $10,000 | 0.0% | $369.03 | 0.0% | COM | 91324P102 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $5,000 | 0.0% | $20.00 | +101.7% | COM | 736508847 |